Guess afte_老虎社区_美港股上老虎

2021-11-30

Guess after the bullish comment , he shorted yesterday and post such answer today!!

'This is not going to be good' -- Moderna CEO on what scientists are telling him about the omicron coronavirus variant

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":609693298,"tweetId":"609693298","gmtCreate":1638274824880,"gmtModify":1638274825160,"author":{"id":3572916667219493,"idStr":"3572916667219493","authorId":3572916667219493,"authorIdStr":"3572916667219493","name":"Zarkness","avatar":"https://static.tigerbbs.com/4b8c61830c4883c4232aece921d89d14","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":54,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Guess after the bullish comment ,&nbsp;he shorted yesterday and post such answer today!!&nbsp;</p></body></html>","htmlText":"<html><head></head><body><p>Guess after the bullish comment ,&nbsp;he shorted yesterday and post such answer today!!&nbsp;</p></body></html>","text":"Guess after the bullish comment , he shorted yesterday and post such answer today!!","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/609693298","repostId":2187589177,"repostType":4,"repost":{"id":"2187589177","kind":"highlight","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1638271821,"share":"https://www.laohu8.com/m/news/2187589177?lang=&edition=full","pubTime":"2021-11-30 19:30","market":"us","language":"en","title":"'This is not going to be good' -- Moderna CEO on what scientists are telling him about the omicron coronavirus variant","url":"https://stock-news.laohu8.com/highlight/detail?id=2187589177","media":"Dow Jones","summary":"Moderna CEO Stephane Bancel has left no doubt whether he's taking a glass half-full or half-empty ap","content":"<p>Moderna&nbsp;CEO Stephane Bancel has left no doubt whether he's taking a glass half-full or half-empty approach to the emergence of the new omicron coronavirus variant.</p>\n<p>He told the Financial Times there's no world where current vaccines are as effective as against the delta variant. And he suggested the dropoff could be significant.</p>\n<p></p>\n<blockquote>\n “I think it’s going to be a material drop. I just don’t know how much because we need to wait for the data. But all the scientists I’ve talked to . . . are like, ‘This is not going to be good’.”\n</blockquote>\n<p></p>\n<p>The interview put another scare into financial markets, with futures on the Dow industrials contract losing more than 500 points. \"The major vaccine makers have offered timelines of two to six weeks for assessing its vaccine evading capabilities, and in the meantime, travel shutdowns and behaviour modification are a risk as we await anecdotal and statistical evidence of the spread of the virus and its virulence,\" said Steen Jakobsen, chief investment officer at Saxo Bank.</p>\n<p>Moderna had previously announced that data on the abillity of its vaccine to neutralize omicron variant would be expected in weeks as it works to rapidly advance a booster candidate specifically against the variant.</p>\n<p>Product sales from its coronavirus vaccine accounted for $4.81 billion of Moderna's $4.97 billion in revenue in the third quarter.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>'This is not going to be good' -- Moderna CEO on what scientists are telling him about the omicron coronavirus variant</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n'This is not going to be good' -- Moderna CEO on what scientists are telling him about the omicron coronavirus variant\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-11-30 19:30</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Moderna&nbsp;CEO Stephane Bancel has left no doubt whether he's taking a glass half-full or half-empty approach to the emergence of the new omicron coronavirus variant.</p>\n<p>He told the Financial Times there's no world where current vaccines are as effective as against the delta variant. And he suggested the dropoff could be significant.</p>\n<p></p>\n<blockquote>\n “I think it’s going to be a material drop. I just don’t know how much because we need to wait for the data. But all the scientists I’ve talked to . . . are like, ‘This is not going to be good’.”\n</blockquote>\n<p></p>\n<p>The interview put another scare into financial markets, with futures on the Dow industrials contract losing more than 500 points. \"The major vaccine makers have offered timelines of two to six weeks for assessing its vaccine evading capabilities, and in the meantime, travel shutdowns and behaviour modification are a risk as we await anecdotal and statistical evidence of the spread of the virus and its virulence,\" said Steen Jakobsen, chief investment officer at Saxo Bank.</p>\n<p>Moderna had previously announced that data on the abillity of its vaccine to neutralize omicron variant would be expected in weeks as it works to rapidly advance a booster candidate specifically against the variant.</p>\n<p>Product sales from its coronavirus vaccine accounted for $4.81 billion of Moderna's $4.97 billion in revenue in the third quarter.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4139":"生物科技","BK4568":"美国抗疫概念","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4532":"文艺复兴科技持仓","MRNA":"Moderna, Inc.","BK4548":"巴美列捷福持仓","BK4551":"寇图资本持仓","BK4534":"瑞士信贷持仓"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2187589177","content_text":"Moderna CEO Stephane Bancel has left no doubt whether he's taking a glass half-full or half-empty approach to the emergence of the new omicron coronavirus variant.\nHe told the Financial Times there's no world where current vaccines are as effective as against the delta variant. And he suggested the dropoff could be significant.\n\n\n “I think it’s going to be a material drop. I just don’t know how much because we need to wait for the data. But all the scientists I’ve talked to . . . are like, ‘This is not going to be good’.”\n\n\nThe interview put another scare into financial markets, with futures on the Dow industrials contract losing more than 500 points. \"The major vaccine makers have offered timelines of two to six weeks for assessing its vaccine evading capabilities, and in the meantime, travel shutdowns and behaviour modification are a risk as we await anecdotal and statistical evidence of the spread of the virus and its virulence,\" said Steen Jakobsen, chief investment officer at Saxo Bank.\nModerna had previously announced that data on the abillity of its vaccine to neutralize omicron variant would be expected in weeks as it works to rapidly advance a booster candidate specifically against the variant.\nProduct sales from its coronavirus vaccine accounted for $4.81 billion of Moderna's $4.97 billion in revenue in the third quarter.","news_type":1},"isVote":1,"tweetType":1,"viewCount":793,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":70,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/609693298"}